New Lancet Global Health: ‘Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden’

Bronner Gonçalves, Epidemiologist, London School of Hygiene and Tropical Medicine, has released a new article on the ‘Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden’, in Lancet Global Health April 2022.

“Better ways to prevent Group B Streptococcus infection are urgently needed to save babies on all continents and avoid the long-term consequences to their lives and their families.”

Bronner Gonçalves, Epidemiologist, LSHTM

Group B streptococcus (GBS) colonisation during pregnancy can lead to invasive GBS disease (iGBS) in infants, including meningitis or sepsis, with a high mortality risk. Other outcomes include stillbirths, maternal infections, and prematurity. There are data gaps, notably regarding neurodevelopmental impairment (NDI), especially after iGBS sepsis, which have limited previous global estimates. In this study, we aimed to address this gap using newly available multicountry datasets.

Please find access to the article here: https://www.sciencedirect.com/science/article/pii/S2214109X22000936